Consider TSI’s assistance as you endeavor to be world-class in your health industry with even greater efficiency and digital transformation.
TSI pairs deep experience supporting regulated medical product organizations (medical devices, diagnostics, pharma, and biotech) with a proven, repeatable methodology to drive measurable organizational transformation. We understand the realities that make this work different in your world—quality systems, validation, data integrity, audit readiness, risk management, and cross-functional dependencies that span R&D, QA/RA, manufacturing, supply chain, commercial, and shared services.
TSI has had the good fortune to work with organizations including Abbott Laboratories, Avexis (since acquired by Novartis), Sagent Pharmaceuticals, and others.

We begin with a rapid, focused assessment of the areas that matter most—typically the processes and decision points that are creating friction, slowing execution, or increasing compliance and operational risk. Through targeted stakeholder interviews, workflow and handoff mapping, and a practical review of enabling systems and data, we establish a clear, fact-based view of the current state: what’s working, what’s not, and why.
From there, we define an ideal future state that is both ambitious and realistic—one that improves speed, quality, and accountability without weakening the controls that protect the business. We translate that future state into a prioritized set of recommendations and an execution roadmap across people, process, technology, and governance. Recommendations are designed to be actionable and measurable (clear owners, timelines, and KPIs), and—crucially for regulated environments—sustainable, with the right documentation, training, and change enablement to ensure improvements “stick.”
In addition, TSI has deep experience helping organizations evolve as they expand product and service offerings and widen geographic reach—changes that often pressure every part of the operating model. As portfolios broaden and markets expand, companies are forced to rethink how they sell, fulfill, service, and support customers; how they scale manufacturing and distribution; how they structure shared services; and how they maintain consistent quality and compliance across sites, partners, and regions. We help leadership teams evaluate when the business model needs to shift (e.g., new channels, new service models, different make/buy decisions, new partnerships), and then redesign the capabilities required to execute—processes, org structure, governance, systems, and data.
Practically, this means helping clients standardize where it creates leverage (core master data, quality processes, reporting, controls) while preserving flexibility where differentiation matters (customer experience, specialized products, regional needs). The result is a scalable, compliant operating model that can absorb growth without creating chaos—or a trail of “temporary” workarounds that become permanent.
The following are the most frequent service areas we employ to help our healthcare clients:
Our consulting team works to gain a clear understanding of your pharma or biotech or healthcare company’s current state processes, organizational objectives, and ideal future state. We then use this, combined with the context of the Pharmaceutical Regulated Industry knowledge to develop a customized set of actions and recommendations that will facilitate the achievement of those stated goals. These recommendations are actionable, measurable, and most importantly in this industry, sustainable.
Our fees are extremely competitive in the pharmaceutical consulting market place. We start our projects with an estimate of our fees and have an outstanding track record of completing our work within our estimated ranges.
Yes, significantly. And, in recent months we have successfully adapted our fact-finding and analysis techniques so that we can work in a remote manner. We continue to have great success engaging our stakeholders, so they provide their input while feeling heard.